UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Ketone bodies: from enemy to friend and guardian angel

BMC medicine, 2021-12, Vol.19 (1), p.313-313, Article 313

2021

Volltextzugriff (PDF)

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment

Diabetologia, 2016-01, Vol.59 (1), p.13-20

2016

Volltextzugriff (PDF)

Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data

Diabetes, obesity & metabolism, 2023-03, Vol.25 (3), p.767-775

2023

Volltextzugriff (PDF)

Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept

Diabetes care, 2015-10, Vol.38 (10), p.1827-1834

2015

Volltextzugriff (PDF)

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study

Cardiovascular diabetology, 2024-07, Vol.23 (1), p.1-11, Article 256

2024

Volltextzugriff (PDF)

Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes

BMC medicine, 2017-04, Vol.15 (1), p.88-88, Article 88

2017

Volltextzugriff (PDF)

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes

Diabetes care, 2009-03, Vol.32 (3), p.421-423

2009

Volltextzugriff (PDF)

Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?

Diabetes/metabolism research and reviews, 2016-03, Vol.32 (3), p.316-324

2016

Volltextzugriff (PDF)

Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow‐up registry

Pediatric diabetes, 2022-12, Vol.23 (8), p.1602-1612

2022

Volltextzugriff (PDF)

Diabetes mellitus Typ 1 und autoimmunpolyglanduläres Syndrom (APS)

Diabetologe, 2022, Vol.18 (1), p.4-11

2022

Volltextzugriff (PDF)

Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)

PloS one, 2012-03, Vol.7 (3), p.e33108

2012

Volltextzugriff (PDF)

Association of IL-1ra and Adiponectin With C-Peptide and Remission in Patients With Type 1 Diabetes

Diabetes (New York, N.Y.), 2008-04, Vol.57 (4), p.929-937

2008

Volltextzugriff (PDF)

Foodborne transmission of bovine spongiform encephalopathy to non-human primates results in preclinical rapid-onset obesity

PloS one, 2014-08, Vol.9 (8), p.e104343

2014

Volltextzugriff (PDF)

The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial)

PloS one, 2013-08, Vol.8 (8), p.e72440-e72440

2013

Volltextzugriff (PDF)

Leukocyte Counts and T-Cell Frequencies Differ Between Novel Subgroups of Diabetes and Are Associated With Metabolic Parameters and Biomarkers of Inflammation

Diabetes (New York, N.Y.), 2021-11, Vol.70 (11), p.2652-2662

2021

Volltextzugriff (PDF)

Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon‐like peptide‐1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow‐Up Registry

Diabetes, obesity & metabolism, 2023-07, Vol.25 (7), p.1813-1822

2023

Volltextzugriff (PDF)

Digital Diabetes Management: A Literature Review of Smart Insulin Pens

Journal of diabetes science and technology, 2022-05, Vol.16 (3), p.587-595

2022

Volltextzugriff (PDF)

Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial

PloS one, 2011-03, Vol.6 (3), p.e17554

2011

Volltextzugriff (PDF)

Increased spontaneous CCL2 (MCP‐1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14

Diabetes/metabolism research and reviews, 2021-10, Vol.37 (7), p.e3431-n/a

2021

Volltextzugriff (PDF)

Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes

Diabetes (New York, N.Y.), 2008-10, Vol.57 (10), p.2768-2773

2008

Volltextzugriff (PDF)

Mechanisms Underlying the Onset of Oral Lipid―Induced Skeletal Muscle Insulin Resistance in Humans

Diabetes (New York, N.Y.), 2013-07, Vol.62 (7), p.2240-2248

2013

Volltextzugriff (PDF)

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

Nature medicine, 2024-07, Vol.30 (7), p.2037-2048

2024

Volltextzugriff (PDF)

Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 Trials

Diabetes, obesity & metabolism, 2018-06, Vol.20 (6), p.1490-1498

2018

Volltextzugriff (PDF)

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study

Diabetes care, 2009-03, Vol.32 (3), p.421-423

2009

Volltextzugriff (PDF)

Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)

Diabetes care, 2014-08, Vol.37 (8), p.2326-2333

2014

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Aktive Filter

KollektionScienceDirect Journals (5 years ago - present)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(131)

Publikationsform

Artikel
(136)

Sprache

Deutsch
(74)
Englisch
(62)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(49)
Humans
(47)
Diabetes
(39)
Endocrinology & Metabolism
(38)
Diabetes Mellitus
(27)
Adult
(26)
Female
(25)
Male
(24)
Insulin
(23)
Diabetes Mellitus, Type 1 - Immunology
(18)
Type 1 Diabetes
(18)
Autoimmune Diseases
(17)
Biological And Medical Sciences
(17)
Diabetes. Impaired Glucose Tolerance
(16)
Endocrine Pancreas. Apud Cells
(16)
Endocrinopathies
(16)
Medical Sciences
(16)
Middle Aged
(14)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Ketone bodies: from enemy to friend and guardian angel

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment

Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data

Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study

Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes

Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?

Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow‐up registry

Diabetes mellitus Typ 1 und autoimmunpolyglanduläres Syndrom (APS)

Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)

Association of IL-1ra and Adiponectin With C-Peptide and Remission in Patients With Type 1 Diabetes

Foodborne transmission of bovine spongiform encephalopathy to non-human primates results in preclinical rapid-onset obesity

The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial)

Leukocyte Counts and T-Cell Frequencies Differ Between Novel Subgroups of Diabetes and Are Associated With Metabolic Parameters and Biomarkers of Inflammation

Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon‐like peptide‐1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow‐Up Registry

Digital Diabetes Management: A Literature Review of Smart Insulin Pens

Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial

Increased spontaneous CCL2 (MCP‐1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14

Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes

Mechanisms Underlying the Onset of Oral Lipid―Induced Skeletal Muscle Insulin Resistance in Humans

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 Trials

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study

Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)

Aktive Filter

Suchergebnisse filtern